Bozkaya, Y. Et Al. 2017. Gastric adenocarcinoma with neuroendocrine differentiation: Clinicopathological features and efficacy of modified DCF chemotherapy. Journal of B.U.ON. , vol.22, no.4 , 919-925.

Bozkaya, Y., Ozdemir, N., Colak, A., & ZENGİN, N., (2017). Gastric adenocarcinoma with neuroendocrine differentiation: Clinicopathological features and efficacy of modified DCF chemotherapy. Journal of B.U.ON. , vol.22, no.4, 919-925.

Bozkaya, Yakup Et Al. "Gastric adenocarcinoma with neuroendocrine differentiation: Clinicopathological features and efficacy of modified DCF chemotherapy," Journal of B.U.ON. , vol.22, no.4, 919-925, 2017

Bozkaya, Yakup Et Al. "Gastric adenocarcinoma with neuroendocrine differentiation: Clinicopathological features and efficacy of modified DCF chemotherapy." Journal of B.U.ON. , vol.22, no.4, pp.919-925, 2017

Bozkaya, Y. Et Al. (2017) . "Gastric adenocarcinoma with neuroendocrine differentiation: Clinicopathological features and efficacy of modified DCF chemotherapy." Journal of B.U.ON. , vol.22, no.4, pp.919-925.

@article{article, author={Yakup Bozkaya Et Al. }, title={Gastric adenocarcinoma with neuroendocrine differentiation: Clinicopathological features and efficacy of modified DCF chemotherapy}, journal={Journal of B.U.ON.}, year=2017, pages={919-925} }